Share
Entrepreneur
The COVID-19 vaccine may spell the end of the pandemic, but while mass vaccination is not available it is vital to stop community transmission. The new antiviral drug MK-4482 / EIDD-2801 or Molnupiravir, has managed to suppress “completely” the transmission of the coronavirus in just 24 hours , according to studies by the Institute of Biomedical Sciences of Georgia State University.
“This is the first demonstration of an orally available drug that quickly blocks the transmission of SARS-CoV-2 , so it could be a game changer,” the researchers explained in the work published in the journal Nature Microbiology .
The antiviral drug was developed at Emory University in Atlanta by the drug innovation company Drug Innovation Ventures at Emory (DRIVE), which was licensed by Ridgeback Biotherapeutics, which partnered with Merck & Co. Molnupiravir was originally designed to treat the flu and prevent the virus from making copies of itself, creating errors during viral RNA replication.
6 Dec 2020
RELATED TOPICS:
Trump Criticizes Judge and His Daughter After Gag Order in Hush-Money Case
13 hours ago
CA Insurance Market ‘in Chaos,’ Says Former Insurance Commissioner. Can Lara Fix It?
14 hours ago
Stock Market Today: S&P 500 Sets a Record After Wall Streets Breaks Out of Its Lull
14 hours ago
House Speaker Mike Johnson Headed to Fresno on April 4
14 hours ago
Bredefeld, Smittcamp Debate the Salary of Valley Children’s CEO
15 hours ago
CA’s Liberal Government Has a Long History of Caving to Special Interests
15 hours ago
Police Had About 90 Seconds to Stop Traffic Before Baltimore Bridge Fell. 6 Workers Are Feared Dead
16 hours ago
NBC Has Cut Ties With Former RNC Head Ronna McDaniel After Employee Objections, Some on the Air
17 hours ago
Here Are Some Numbers That Will Help You Get Your March Madness Fix for the Sweet 16
17 hours ago
Ukrainian Navy Says a Third of Russian Warships in the Black Sea Have Been Destroyed or Disabled